Medtech Business Review

Regulatory requirements, technological advancements, and significant pricing pressure have all contributed to increased pressure on medical device manufacturers in recent years.

Globally, the medical device industry is expanding rapidly and is positioned for sustained growth. By 2027, the global medical device market should reach $671 billion, with a CAGR of 5.2 percent, up from $448 billion in 2019. Device makers face hurdles when it comes to meeting patient demands through innovation and technology development. Keeping up with market demands while concentrating on quality is essential in the competitive medical technology market.

In addition, manufacturing is slowed down by obstacles. A failure to focus on these could result in patient safety concerns, product recalls, and field corrections. The obstacles include growing regulatory requirements, product development, and seamlessly incorporating suppliers into the development processes. Maintaining an efficient production process and managing supplier quality may have long-term consequences for a business if a harsh approach is taken to process development. Furthermore, the digitalization of medical devices raises additional security concerns due to the possibility of patient data being compromised or the introduction of new hazards as a result of a compromised device.

Regulatory compliance requirements in the medical device sector span several countries, business activities, and roles. By inventing and launching new devices that meet unmet patient needs, the medical device industry faces unique compliance challenges. Furthermore, compliance failures can be costly in terms of penalties, remediation costs, and reputational damage. Building a successful compliance program and ensuring the industry's future viability requires identifying, assessing, and reducing compliance risks.

The key challenges in sustaining compliance in the medical device industry are described below:

Concerns about complex suppliers: A positive relationship between the provider and the consumer is essential to any business's success. The ideal supply chain process ensures that high-quality goods are produced with little material waste. In spite of this, most firms struggle with supply chain complexity. Medical device manufacturers face several obstacles, as well. Occasionally, clients fail to establish effective change control processes with suppliers. When a supplier makes changes to a procedure, raw material, or inspection without the customer's consent, it creates noncompliance, and more importantly, it can compromise patients' safety. Alternatively, if the client develops a change control that requires the supplier to obtain approval for every modification before implementation, this may result in a multitude of process variations. It is possible that some alterations will have a minor or no effect. In order to maintain an effective operation without compromising quality or customer service, a balance between change control methods is necessary.

Modernizing compliance: Advancing into the future: Regulatory requirements, technological advancements, and significant pricing pressure have all contributed to increased pressure on medical device enterprises in recent years. Even more, justification is provided by the unprecedented events of the pandemic for modernizing compliance and elevating value and partnerships within companies and with external stakeholders.

Compliance businesses have traditionally focused on solutions and services and transactional data analysis to determine what went wrong. The regulatory compliance function should transition from hindsight to foresight, generate knowledge and employ methods that facilitate business success. Modernizing the regulatory compliance framework and adopting new compliance strategies are necessary to achieve this. Compliance and regulatory organizations have the opportunity to improve their alignment with business goals and regulations, as well as their responsiveness to external opportunities, challenges, and pressures today. In order to effectively serve their enterprises through vital business partnerships, modern compliance operations must remain risk-aware and efficient.

Security in cyberspace: Industry practices have been altered by artificial intelligence (AI), digitization, and the Internet of things (IoT). Technologies have enabled self-monitoring, diagnosis, and better integration and connectivity between patients and clinicians. These developments require security. Data is captured, stored, and shared across several platforms by medical equipment. Increasing numbers of them rely on software that is susceptible to technical errors and may expose devices to security risks. Medical equipment can be accessed and altered by hackers. Patient safety is compromised as a result of these concerns.

The importance of proactive monitoring of product field performance for software vulnerabilities cannot be overstated. Manufacturers should carefully examine cybersecurity as part of product development requirements and outline what must be done to maintain patients' safety and mitigate associated risks, such as using secure communication routes and cloud storage. The FDA requires producers to comply with cybersecurity pre- and post-market requirements and to resolve any security issues before introducing products.